Cover Image

OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma

Liver hepatocellular carcinoma (LIHC) is one of the most common malignant tumors in the world with an increasing number of fatalities. Identification of novel prognosis biomarker for LIHC may improve treatment and therefore patient outcomes. The availability of public gene expression profiling data...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yang An (Author), Qiang Wang (Author), Guosen Zhang (Author), Fengjie Sun (Author), Lu Zhang (Author), Haojie Li (Author), Yingkun Li (Author), Yanyu Peng (Author), Wan Zhu (Author), Shaoping Ji (Author), Xiangqian Guo (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

H/ACA snoRNP Gene Family as Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma
by: Zhang M, et al.
Published: (2021)

Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma
by: Nan Zhang, et al.
Published: (2024)

PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
by: Lan C, et al.
Published: (2023)

An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment
by: Yingxi Du, et al.
Published: (2021)

Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma
by: Yi Shi, et al.
Published: (2021)

Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma
by: Xiangqian Zhang, et al.
Published: (2023)

Comprehensive Analysis of NABP2 as a Prognostic Biomarker and Its Correlation with Immune Infiltration in Hepatocellular Carcinoma
by: Li B, et al.
Published: (2023)

INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
by: Wenke Li, et al.
Published: (2023)

Role of ATF3 as a prognostic biomarker and correlation of ATF3 expression with macrophage infiltration in hepatocellular carcinoma
by: Lijuan Li, et al.
Published: (2021)

ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma
by: Xinyao Hu, et al.
Published: (2023)

Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
by: Amira Isaac, et al.
Published: (2021)

Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer
by: Fengjie Lin, et al.
Published: (2024)

Sex-Specific Differences in Related Indicators of Blood Pressure in School-Age Children With Overweight and Obesity: A Cross-Sectional Study
by: Hongmei He, et al.
Published: (2021)

Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma
by: Yangyang Zhang, et al.
Published: (2022)

Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma
by: Jun Liu, et al.
Published: (2022)

Construction a six-gene prognostic model for hepatocellular carcinoma based on WGCNA co-expression network
by: Tian Wang, et al.
Published: (2024)

Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC
by: Li-xin Du, et al.
Published: (2024)

Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
by: Huang Ao, et al.
Published: (2021)

Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes
by: Sainan Duan, et al.
Published: (2022)

C-reactive Protein Overexpression in the Background Liver of Hepatitis B Virus-Associated Hepatocellular Carcinoma Is a Prognostic Biomarker
by: Jin Ho Shin, et al.
Published: (2018)

Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score
by: Yongjiang Li, et al.
Published: (2022)

miR-940 is a new biomarker with tumor diagnostic and prognostic value
by: Hongxiang Li, et al.
Published: (2021)

Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors
by: Ning Luo, et al.
Published: (2023)

Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma
by: Dan-Dan Zhang, et al.
Published: (2021)

Imaging prognostication and tumor biology in hepatocellular carcinoma
by: Diana Kadi, et al.
Published: (2023)

Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma
by: Anyin Yang, et al.
Published: (2024)

Insights about exosomal circular RNAs as novel biomarkers and therapeutic targets for hepatocellular carcinoma
by: Haiyan Zhang, et al.
Published: (2024)

Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma
by: Dai T, et al.
Published: (2021)

Correction: Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma
by: Anyin Yang, et al.
Published: (2024)

Identification of long non-coding RNA-related and -coexpressed mRNA biomarkers for hepatocellular carcinoma
by: Fan Zhang, et al.
Published: (2019)

Identification of prognostic biomarkers of breast cancer based on the immune-related gene module
by: Ruijuan Wang, et al.
Published: (2023)

Prognostic value and immune infiltration analyses of cuproptosis-related genes in hepatocellular carcinoma
by: Junjie Li, et al.
Published: (2023)

The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
by: Yangkyu Lee, et al.
Published: (2018)

A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
by: Dongxue Fu, et al.
Published: (2024)

Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma
by: Gao W, et al.
Published: (2022)

Immunotherapies for advanced hepatocellular carcinoma
by: Li-Yang Sun, et al.
Published: (2023)

Early changes in soluble intracellular adhesion molecule‐1 as prognostic biomarkers to immune checkpoint inhibitor
by: Dongmei Ji, et al.
Published: (2023)

RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma
by: Hao Peng, et al.
Published: (2022)

A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics
by: Menghan Zhang, et al.
Published: (2024)

Prognostic Value of Biomarkers in Children and Adolescents With Orthostatic Intolerance
by: Huijuan Yan, et al.
Published: (2021)